Prada A - Search Results

1

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan.

Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N, Cascinelli N. Vaglini M, et al. Among authors: prada a. Cancer. 1994 Jan 15;73(2):483-92. doi: 10.1002/1097-0142(19940115)73:2<483::aid-cncr2820730238>3.0.co;2-s. Cancer. 1994. PMID: 8293417 Clinical Trial.

2

Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study.

Belli F, Arienti F, Rivoltini L, Santinami M, Mascheroni L, Prada A, Ammatuna M, Marchesi E, Parmiani G, Cascinelli N, et al. Belli F, et al. Among authors: prada a. Melanoma Res. 1992 Nov;2(4):263-71. doi: 10.1097/00008390-199211000-00007. Melanoma Res. 1992. PMID: 1490114

3

Limb-salvage procedure in two patients with spindle cell carcinoma of the lower extremities using isolation perfusion.

Vaglini M, Andreola S, Attili A, Belli F, Marolda R, Nava M, Prada A, Santinami M, Cascinelli N. Vaglini M, et al. Among authors: prada a. Tumori. 1985 Jun 30;71(3):271-5. doi: 10.1177/030089168507100309. Tumori. 1985. PMID: 4024282

4

Hyperthermic antiblastic perfusion in the treatment of cancer of the extremities.

Vaglini M, Andreola S, Attili A, Belli F, Marolda R, Nava M, Prada A, Santinami M, Cascinelli N. Vaglini M, et al. Among authors: prada a. Tumori. 1985 Aug 31;71(4):355-9. doi: 10.1177/030089168507100406. Tumori. 1985. PMID: 4049537

5

Regional perfusion at high temperature in treatment of stage IIIA-IIIAB melanoma patients.

Vaglini M, Ammatuna M, Nava M, Prada A, Rovini D, Santinami M, Cascinelli N. Vaglini M, et al. Among authors: prada a. Tumori. 1983 Dec 31;69(6):585-8. doi: 10.1177/030089168306900617. Tumori. 1983. PMID: 6665881

6

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2.

Arienti F, Belli F, Rivoltini L, Gambacorti-Passerini C, Furlan L, Mascheroni L, Prada A, Rizzi M, Marchesi E, Vaglini M, et al. Arienti F, et al. Among authors: prada a. Cancer Immunol Immunother. 1993 May;36(5):315-22. doi: 10.1007/BF01741170. Cancer Immunol Immunother. 1993. PMID: 8477417 Free PMC article.

7

A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients.

Cascinelli N, Belli F, Marchini S, Marolda R, Prada A, Sciorelli G, Villani F, Gambacorti-Passerini C, Galazka A, Parmiani G. Cascinelli N, et al. Among authors: prada a. Tumori. 1989 Jun 30;75(3):233-44. doi: 10.1177/030089168907500309. Tumori. 1989. PMID: 2788945

8

A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effects.

Marolda R, Belli F, Prada A, Villani F, Gambacorti-Passerini C, Galazka A, Parmiani G, Cascinelli N. Marolda R, et al. Among authors: prada a. Tumori. 1987 Dec 31;73(6):575-84. doi: 10.1177/030089168707300606. Tumori. 1987. PMID: 3501624

9

Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.

Vaglini M, Belli F, Marolda R, Prada A, Santinami M, Cascinelli N. Vaglini M, et al. Among authors: prada a. Eur J Surg Oncol. 1987 Apr;13(2):127-9. Eur J Surg Oncol. 1987. PMID: 3556593

10

[Use of buprenorphine after right hepatectomy].

Manzi R, Rizzi M, D'Elia F, Perego G, Scaricabarozzi I, Prada A, Terno G. Manzi R, et al. Among authors: prada a. Minerva Anestesiol. 1991 Jun;57(6):379-82. Minerva Anestesiol. 1991. PMID: 1754079 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters